Low-T Drug Research

by azguy | Aug 27, 2025

Medical Research on Testosterone and Low-T Drugs A study conducted by UCLA and the National Institutes of Health and Consolidated Research found that testosterone drugs substantially raise the risk of heart attack. A 2014 study conducted jointly by UCLA and the...

Low-T Side Effects

by azguy | Aug 27, 2025

Side Effects of Testosterone and Low-T Drugs Patients who are using the Low-T drugs AndroGel, AndroDerm, Axiron, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim or Testopel, should immediately consult their physicians to discuss continued use of...

Attorney for Testosterone Therapy Drug Patients Urges FDA to Prevent “Off Label” Use of Medications

by azguy | Jul 30, 2014

Phoenix, Arizona—Phoenix Attorney Jonathan O’Steen has asked the federal Food and Drug Administration (FDA) to take action to prevent off-label use of the testosterone therapy drugs AndroGel, AndroDerm, Axiron, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta,...

Manufacturers of Androgel Want Coordination of Federal and State Testosterone Lawsuits

by azguy | Jul 29, 2014

Chicago, Illinois—In June, all testosterone therapy lawsuits previously filed in various federal courts throughout the United States were consolidated in a single court – the U.S. District Court for the Northern District of Illinois.  The advantages of...